KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amgen (AMGN) Depreciation & Amortization (CF) (2016 - 2025)

Historic Depreciation & Amortization (CF) for Amgen (AMGN) over the last 17 years, with Q4 2025 value amounting to $1.1 billion.

  • Amgen's Depreciation & Amortization (CF) fell 1896.92% to $1.1 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $5.2 billion, marking a year-over-year decrease of 760.01%. This contributed to the annual value of $5.2 billion for FY2025, which is 760.01% down from last year.
  • Amgen's Depreciation & Amortization (CF) amounted to $1.1 billion in Q4 2025, which was down 1896.92% from $1.3 billion recorded in Q3 2025.
  • Over the past 5 years, Amgen's Depreciation & Amortization (CF) peaked at $1.4 billion during Q2 2024, and registered a low of $828.0 million during Q2 2022.
  • For the 5-year period, Amgen's Depreciation & Amortization (CF) averaged around $1.1 billion, with its median value being $905.5 million (2022).
  • Its Depreciation & Amortization (CF) has fluctuated over the past 5 years, first surged by 5625.0% in 2024, then tumbled by 1896.92% in 2025.
  • Quarter analysis of 5 years shows Amgen's Depreciation & Amortization (CF) stood at $852.0 million in 2021, then grew by 6.92% to $911.0 million in 2022, then soared by 51.48% to $1.4 billion in 2023, then increased by 1.23% to $1.4 billion in 2024, then dropped by 18.97% to $1.1 billion in 2025.
  • Its Depreciation & Amortization (CF) was $1.1 billion in Q4 2025, compared to $1.3 billion in Q3 2025 and $1.3 billion in Q2 2025.